News
Honoraria: AstraZeneca, Daiichi Sankyo/AstraZeneca, Eisai Europe, Ltd, Zymeworks, Puma Biotechnology, Roche Pharma AG, Seagen, Solti, Phillips Health Works, Pfizer, Pierre Fabre, Exeter ...
In response to the deal, Vor's stock price more than doubled in premarket trading, while RemeGen’s stock price in Hong Kong dropped 18% Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback